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ABSTRACT
Mismatch Repair (MMR) is closely linked to DNA
replication; however, other than the role of the
replicative sliding clamp (PCNA) in various MMR
functions, the linkage between DNA replication and
MMR has been difficult to investigate. Here we use
an in vitro DNA replication system based on simian
virus 40, to investigate MMR recruitment to repli-
cating DNA. Both DNA replication and MMR proteins
are recruited to replicating DNA in an origin-
dependent fashion. Primer synthesis is required for
recruitment of both PCNA and MMR proteins, but
not for recruitment of the single-stranded DNA-
binding protein (RPA). Blocking PCNA recruitment
to replicating DNA with a p21-based polypeptide
blocks PCNA and MMR, but not RPA recruitment.
Once PCNA and subsequent proteins required for
replication are loaded onto DNA, addition of p21
leaves PCNA on the replicating DNA, but actively
displaces MMR proteins. These findings indicate
that the MMR machinery is recruited to replicating
DNA through its interaction with PCNA, and sug-
gests that this occurs via binding of the MMR
proteins to the multi-protein interaction sites on
PCNA. These studies demonstrate the utility of
this system for further investigation of the role of
DNA replication in MMR.
INTRODUCTION
Post-replicative Mismatch Repair (MMR) is crucial for
repairing base–base mismatches and insertion/deletion
loops (IDLs) generated primarily during DNA replication
by nucleotide mis-incorporation and DNA slippage
errors (1–4). Mutations in MMR genes are associated
with various sporadic cancers as well as hereditary
non-polyposis colorectal cancer (5–7). MMR is well
studied in Escherichia coli where the entire repair reaction
has been reconstituted in vitro and all the required MMR
proteins have been identiﬁed and puriﬁed (8,9). Following
DNA replication, mismatches on the DNA are recognized
by MutS homodimer. The assembly of MutS–MutL
complexes at mismatches activates the downstream
endonuclease, MutH, the mispaired nucleotide(s) are
removed and DNA is re-synthesized (10,11).
In E. coli, the association of MMR with newly
synthesized DNA is due to the requirement for MutH.
MutH is dependent on the transiently hemi-methylated
nature of newly synthesized DNA for its function in
MMR (8). Eukaryotes and bacteria other than gram-
negatives, which have homologs for MutS and MutL,
have no MutH homolog (12). While the eukaryotic
MMR machinery is clearly present at DNA replication
foci (13), showing its association with the DNA replica-
tion process, the mechanism behind the association of
MMR with eukaryotic replication remains unclear.
The interaction of the replicative sliding clamp (PCNA)
with MutS complexes have been suggested to be a possible
mechanism for recruiting MMR to replicating DNA
(13–15); however, due to a lack of experimental systems
that can concurrently investigate DNA replication and
MMR, direct evidence showing PCNA plays a role in
recruitment of MMR to replicating DNA has remained
lacking.
PCNA has been shown to function in various steps
of MMR. PCNA is a processivity factor for DNA
polymerases d and e (16) and as such is required in the
DNA re-synthesis step of MMR (17–20). PCNA has been
shown to interact with exonuclease I (EXOI) and to
colocalize with EXOI at DNA replication foci (21). PCNA
is essential for 30 to 50 excision but not for 50 to 30 excision.
These results suggest diﬀerential requirement for PCNA
in 30 to 50 and 50 to 30 nick-directed excision pathways
(22,23). However, it is unknown how PCNA functions
diﬀerentially in the excision steps. PCNA has been
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complexes in yeast as well as humans (15,24–27). Yeast
and human MSH3 and MSH6 proteins contain a
conserved PCNA-binding motif, known as the PCNA
Interacting Protein motif (PIP box) (13,28,29). PCNA
increases the speciﬁc binding of yeast MSH2–MSH6
complex to DNA mismatches as shown by gel-mobility
shift assays (29), and has been proposed to possibly
help target MMR to newly replicated DNA (14).
However, there has been no direct data to support
this model.
Studies herein utilize a Simian Virus 40 (SV40)
in vitro DNA replication system to evaluate the role of
PCNA in the recruitment of the MMR machinery to
replicating DNA. We observe the recruitment of MutSa
and MutSb complexes along with MutL Homolog 1
(MLH1) to replicating SV40 DNA in a replication origin-
dependent manner. This recruitment is dependent on
PCNA; and moreover, is dependent on the availability
of the conserved multi-protein interaction sites on
PCNA. These results are the ﬁrst direct demonstration
that MMR is targeted to newly replicated DNA through
its interactions with PCNA, and indicate that SV40
is a viable system for the study of the interaction between
DNA replication and MMR.
MATERIALS AND METHODS
Antibodies
SV40-Tag antibodies, pAb419- and pAb101, and human-
RPA70 antibody, Mab9 have been described previously
(30,31). Anti-PCNA (pc10), -MutS Homolog 2 (MSH2)
and –MutS Homolog (MSH3) antibodies were purchased
from Santa Cruz. MLH1 antibody was purchased from
BD biosciences. MSH6 antibody was ordered from
Novus.
Chemicals
[a-
32P]-dATP was purchased from GE Health Sciences.
Aphidicolin was purchased from Sigma and dissolved
in 95% (v/v) ethanol (ﬁnal concentration 1mg/ml).
Cellcultures
Human embryonic kidney 293 cells were grown in
suspension at 378C in Jolik’s modiﬁed Eagle medium
(ICN Chemicals) and 5% calf serum (Invitrogen).
Hypotonic cell extracts were prepared as described (32).
The cell extracts were further clariﬁed by ultra-centrifuga-
tion at 100000g for 30min.
Plasmids andproteins
The SV40 replication plasmids pSV010 ori(+) and
pSV010 ori( ) plasmids have been described previously
(33,34). The plasmids were transformed and propagated
in E. coli (JM109). Plasmid DNA was isolated by
Qiagen DNA extraction kit as per the manufacturer’s
recommendations. Supercoiled DNA was further
puriﬁed by velocity sedimentation in a 5–20% sucrose
gradient. Tag was expressed by baculovirus infection of
High-Five insect cells (Invitrogen) and puriﬁed by
immunoaﬃnity chromatography using pAb101
monoclonal antibody as described earlier (35–37). The
pGEX-p21C plasmid was a kind gift from Dr Anindya
Dutta and pGEX-p21Cmut plasmid was generated by
site-directed mutagenesis where amino acid residue 147
(methionine) was substituted to alanine using the
Quickchange kit (Stratagene) as per the manufacturer’s
instructions. The plasmids were transformed into the
E.coli expression strain BL21 (DE3) (38). Cells were
grown to an OD of 0.6 and then induced with 0.4mM
isopropyl-1-thio-P-D-galactopyranoside (IPTG) for 4h.
The proteins were puriﬁed with glutathione-Sepharose
beads (GE Biosciences) as described (39). Bacterially
expressed PCNA was puriﬁed as described (40).
In vitro SV40DNA replication reaction, gel
filtration and proteinrecruitment assay
In vitro SV40 DNA replication was assembled as
previously described (32). Plasmid DNA [pSV010 ori(+)
or pSV010 ori( )] measuring 450–675ng was incubated
with 2.25mg of Tag, 0.1mg/ml of bovine serum albumin
(BSA), 9.375mg of creatine phosphokinase (CPK),
450–750mg of 293 cell extracts and Replication Buﬀer
[30mM HEPES (pH 7.5), 40mM creatine phosphate,
7mM MgCl2, 4mM ATP, 200mM CTP, 200mM UTP,
200mM GTP, 100mM dCTP, 100mM dGTP, 100mM
dTTP, 25mM dATP and 0.5mM DTT] in 150ml.
The reaction was incubated at 378C for 30min and
subjected to gel ﬁltration using a 6ml Biogel A-50m
(Bio-Rad) or AF-02 (Sooner-Scientiﬁc) column in buﬀer
A (25mM Tris pH 7.5, 4mM MgCl2, 50mM NaCl,
1mM DTT and 100mM PMSF). The columns were
developed with buﬀer A and 12 drops ( 400ml) were
collected for each fraction. Protein content was evaluated
using the Bradford method (Bio-Rad). To evaluate
the presence of speciﬁc proteins, the fractions were either
precipitated using 5–20% trichloroacetic acid, or applied
directly to SDS–PAGE, transferred to nitrocellulose
and analyzed by immunoblotting. To evaluate DNA
synthesis, [a-
32P]-dATP was added to the DNA replica-
tion reaction. At the indicated times 2ml was removed,
dotted onto DE81 paper (Whatman) and the incorporated
[a-
32P]-dAMP evaluated after ﬁve washes in 0.5M
Na2HPO4 as described (41).
DNA synthesis capacityof isolated replicating complexes
To test the DNA synthesis capability of isolated replica-
tion complexes, Replication Buﬀer, CPK, BSA and
radiolabeled [a-
32P]-dATP were added to the collected
fractions and incubated at 378C for 45min. The reaction
was terminated by addition of stop buﬀer (20mM Tris pH
7.5, 10mM EDTA pH 8.0, 0.1% SDS, 1mg/mlo f
Proteinase K). The DNA products were isolated, sepa-
rated by 0.8% (w/v) agarose gel electrophoresis and
analyzed by phosphorimage autoradiography.
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Isolation of activereplicating DNA–protein complexes
The in vitro SV40 replication system is useful for the
study of eukaryotic DNA replication because it requires
only one viral protein, large T-Antigen (Tag), and
other replication factors are provided by the host cells
(42,43). MMR has been shown to function on SV40
replicons in primate and human cells, and cell extracts
lacking MMR activity have been shown to support SV40
DNA replication with decreased ﬁdelity; these results
clearly indicate that SV40 is subject to MMR both in vivo
and in vitro (44,45). Here human cell extracts were
used as a source of both DNA replication and MMR
proteins. SV40 DNA replication reactions were assembled
in vitro, incubated for 30min to allow for assembly of
the active replication complexes and subjected to gel
ﬁltration. The fractions collected were analyzed for
protein and DNA. We observed two protein peaks
corresponding to excluded and included fractions
(Figure 1A). As expected, the plasmid DNA was also
found to be excluded, in the same fractions as the
excluded protein peak (Figure 1A and B). These fractions
were analyzed for their ability to support DNA synthesis.
The fractions were incubated with dNTPs, NTPs and
[a-
32P]-dATP to radiolabel any DNA products synthe-
sized. The products were isolated and subjected to gel
electrophoresis. DNA synthesis was observed in the
plasmid-containing fractions but not in the free protein
fractions (Figure 1C, left panel).
We addressed whether these actively replicating
complexes were dependent on the presence of a functional
replication origin on the plasmid template. As a control
we used a plasmid DNA, pSV010 ori( ), whose origin
of replication has been rendered non-functional by
deletion of 4bp within the core origin (33). As expected,
this plasmid also fractionated in the excluded peak
(as in Figure 1B, data not shown). When these fractions
were analyzed for DNA synthesis, unlike the pSV010
ori(+) plasmid, we did not observe DNA synthesis in
the pSV010 ori( ) plasmid-containing fractions
(Figure 1C, right panel). Since, replication proteins
might be bound to the pSV010 ori( ) plasmid, but
would not be able to carry out DNA synthesis due to
the non-functional origin of DNA replication, we
analyzed these fractions for the ability to carry out
DNA synthesis on an ori(+) template. Addition of
pSV010 ori(+) plasmid and additional Tag to these
fractions after gel ﬁltration also did not result in DNA
synthesis (data not shown), consistent with the absence
of essential replication proteins in these fractions
(see below). These results demonstrated that this proce-
dure isolates active replicating complexes in an
origin-dependent manner.
The fractions from the gel ﬁltration separation were
evaluated for the presence of known DNA replication
proteins. The entire fractions were subjected to TCA
precipitation and applied to SDS–PAGE, and subjected
to immunoblotting for several known DNA replication
proteins (Figure 2). The human DNA replication factors,
RPA and PCNA, as well as SV40 Tag, were readily
detectable in the fractions containing the origin-
containing plasmid DNA, pSV010 ori(+) (Figure 2A).
Conversely, these DNA replication proteins could not
be detected in the plasmid-containing fractions from
identical reactions assembled with plasmid DNA contain-
ing the mutated origin, pSV010 ori( ), which contains
a 4nt deletion that inactivates origin function (Figure 2B).
We also showed that recruitment of the cellular
replication factors was dependent on the addition of the
viral replication protein, SV40 Tag (data not shown).
Association ofMMR proteins withreplicating DNA
We then addressed whether MMR proteins associate
with these SV40 replication complexes. We isolated
replicating complexes as described above, and the
fractions were analyzed for the presence of MMR proteins
by immunoblotting. We observed the presence of MMR
proteins in the fractions containing the replicating
complexes assembled with pSV010 ori(+) DNA
(Figure 3A), but not in the corresponding fractions from
reactions assembled with pSV010 ori( ) DNA
(Figure 3B). MutS Homolog 2 (MSH2), which is
common to both the MutSa and MutSb complexes,
MutS Homolog 3 (MSH3) the other subunit of the
MutSb complex, and MutS Homolog 6 (MSH6, the other
subunit of the MutSa complex) (46) were all found to be
recruited to the SV40 replicating complexes, but not to
the corresponding fractions produced with the mutant
origin DNA template (Figure 3 and additional data not
shown). Hence, both MutSa and MutSb are recruited
to replicating SV40 DNA complexes in a replication
origin-dependent manner. [MSH3 was not detectable in
the included protein fractions due to its relatively
low levels in cell extracts (see inset to left of Figure 3A),
and the fact that included proteins get widely spread
across many fractions. However, when recruited to
replicating complexes MSH3 could be detected because
the recruited proteins get concentrated into only two or
three plasmid-containing fractions, thereby maintaining
suﬃcient concentration of MSH3 to be detectable by
immunoblotting]. We also evaluated whether MutL
complexes were recruited to the replicating complexes
by evaluating the presence of MLH1, the common subunit
of the MutL complexes (47). As with the MutS complexes,
MLH1 was recruited to the replicating complexes in
an origin-dependent manner (Figure 3). [In Figure 3A
MLH1 appears to show a lower mobility on SDS–PAGE
in the plasmid-containing fractions than in free protein-
containing fractions. This is due to anomalous electro-
phoresis in this particular experiment, as can be seen by
a similar apparent diﬀerence in PCNA mobility, and as
no diﬀerences in mobility of MLH1 were seen in other
separations (Supplemental Figure 1)].
Primersynthesis is requiredfor recruitment
ofthe MMR proteins
To further understand how MMR proteins are recruited
to replicating DNA, we began to evaluate at which stage
of DNA replication the MMR proteins are recruited.
First, we investigated whether primer synthesis is required
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exogenous dNTPs and NTPs (other than ATP which is
required for origin unwinding) and evaluated recruitment
of MMR and replication proteins. We observed recruit-
ment of RPA to the replicating DNA (Figure 4A),
consistent with expected origin unwinding. We also
observed recruitment of PCNA as well as MSH2, which
we used as a common marker protein for MMR since it is
a common subunit of both MutS complexes (Figure 4A).
As primers are required for PCNA loading (48), this
Figure 1. Isolation of active SV40 DNA replication complexes. SV40 DNA replication reactions were assembled and subjected to gel ﬁltration as
described in Materials and Methods section. Fractions were collected and equal volumes were analyzed for comparative protein content using the
Bio-Rad protein microplate assay, and the absorbance plotted (A). Fractions from a parallel separation were subjected to DNA extraction and
agarose gel electrophoresis to detect the plasmid template (B). Fractions were also supplemented with [a-
32P]-dATP, NTPs and dNTPs, and
incubated at 378C for 45min. The extracted DNA products were subjected to agarose gel electrophoresis and autoradiography (C). The left panel
shows synthesis in fractions from a separation of reactions assembled with a plasmid containing a functional origin of replication [pSV010 ori(+)].
The right panel shows synthesis in fractions from a separation of reactions assembled with a plasmid containing a mutated non-functional origin of
replication [pSV010 ori( )].
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exogenously added dNTPs and NTPs. This result can be
explained by the presence of endogenous dNTPs and
NTPs in human cell extracts, suﬃcient for primer synth-
esis. Primer synthesis by these extracts was veriﬁed by
extensive labeling of short primers upon addition of
[a-
32P]-dATP alone to the reactions (Supplemental
Figure 2). As dialysis was insuﬃcient to remove enough
nucleotides to prevent primer synthesis, we evaluated the
requirement for primer synthesis for protein recruitment
by using the DNA polymerase a-primase inhibitor,
aphidicolin (49,50). Addition of 20mM aphidicolin to the
DNA replication reaction (which blocked dNMP incor-
poration better than withholding exogenous nucleotide,
Supplemental Figure 2) prevented the recruitment of both
MSH2 and PCNA (Figure 4B), consistent with the known
requirement of primers for PCNA loading (48).
Conversely, RPA was still recruited, showing that origin
recognition and unwinding proceeded normally. These
results are consistent with primer synthesis being required
for MMR recruitment.
RecruitmentofMMRproteinsisdependentonPCNAloading
Since recruitment of both MMR proteins and
PCNA appear to require primers, and MMR proteins
are known to interact with PCNA, we addressed whether
PCNA loading is required for MMR protein recruitment.
This was tested by using a p21
WAF1/CIP1 polypeptide
that binds PCNA and inhibits interactions between PCNA
Figure 2. Known replication proteins associate with replicating SV40
DNA in an origin-dependent manner After separation of replicating
SV40 DNA complexes by gel ﬁltration, proteins in the indicated
fractions were precipitated and each entire fraction subjected to
immunoblotting for large T-Antigen (Tag), Replication Protein A
70kDa subunit (RPA70) and Proliferating Cell Nuclear Antigen
(PCNA). Panel (A) shows immunoblots from a reaction assembled
with pSV010 ori(+) and panel (B) shows immunoblots from a reaction
assembled with pSV010 ori( ). As a positive control 5ml of cell extract
(10% of the proteins used in the entire reaction) was loaded in the last
lane of both panel (A) and (B).
Figure 3. MMR proteins associate with replicating DNA in an
origin-dependent manner. Precipitated protein fractions were analyzed
by immunoblotting for MutS Homolog 3 (MSH3), MutS Homolog
2 (MSH2), MutL Homolog 1 (MLH1) and PCNA. Panel (A) shows
reactions assembled with pSV010 ori(+) and panel (B) shows
reactions assembled with pSV010 ori( ). As a positive control
the ﬁrst lane of both panel (A) and (B) contained 5ml of cell extract,
representing 10% of the proteins in the entire reaction. Inset to the
left of Panel A shows a MSH3 immunoblot with increasing levels of
cell extract as indicated.
Figure 4. Primer synthesis is required for MMR protein recruitment to
replicating DNA. DNA replication reactions were subjected to gel
ﬁltration and the precipitated protein fractions were immunoblotted for
MSH2, RPA70 and PCNA. In panel (A) exogenous dNTPs and NTPs
except ATP were omitted. In panel (B)2 0mM aphidicolin was added to
the SV40 DNA replication reaction. As a control for antibody
recognition, lanes marked CE contained 5ml of cell extract representing
7% of the proteins in the entire reaction.
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terminal of p21 contains a conserved PCNA Interacting
Protein (PIP) motif, known as PIP box, shared by
many PCNA interacting proteins (53). A GST-tagged
carboxy-terminal p21 polypeptide consisting of amino-
acids 87–164 (p21C) was added to cell extracts used for
the in vitro DNA replication reactions (38). The eﬀect of
the p21 polypeptide on MMR protein recruitment was
evaluated. RPA70 recruitment was observed in the
presence of p21C. Conversely, we did not observe
recruitment of PCNA or MSH2 to SV40 DNA in the
presence of p21C (Figure 5A). This is consistent with
p21 inhibiting loading of PCNA onto DNA by disrupting
its interaction with RFC, which is required for PCNA
loading (51,54). Addition of excess exogenous PCNA,
which alleviates the inhibitory eﬀect of p21C, restored
recruitment of both PCNA and MSH2 (Figure 5B).
Primer synthesis still occurs in the presence of p21C,
as we observed labeling of small DNA products upon
addition of labeled dATP (data not shown). This
demonstrates that primer synthesis in the absence of
PCNA is not suﬃcient for recruitment of MMR
proteins to the replicating DNA. Rather, recruitment of
MMR proteins to replicating DNA is dependent
on PCNA loading, presumably due to either direct
interaction of MMR proteins with PCNA, or due to
steps in DNA replication subsequent to PCNA loading.
Continued access to themulti-protein binding sites
on PCNA is requiredfor thepresence of MMR on
replicating DNA
In the above experiments we inhibited DNA replication
prior to PCNA loading and after primer synthesis.
The absence of MMR recruitment in these cases could
be due to the lack of later stages of DNA synthesis or the
absence of DNA replication intermediates. We wanted to
ascertain whether once DNA replication complexes
are assembled, if the presence of MMR on replicating
DNA becomes resistant to blocking of PCNA function.
To address this question we carried out the experiment
outlined in Figure 6A. This experiment was designed to
evaluate whether MMR is still present on replicating
DNA if p21C is added after assembly of active DNA
replication/MMR complexes. As a control we veriﬁed
that we could detect early recruitment of RPA, PCNA
and MSH2 to replicating complexes after 20min of
incubation. We were able to clearly detect recruitment of
these factors after 20min (Figure 6B). We also needed to
determine whether p21C could gain access to PCNA on
Figure 5. p21 inhibits recruitment of MMR proteins and PCNA to replicating DNA. In panel (A) p21C (34mg/ml) was added to the SV40 DNA
replication reaction. In panel (B) p21C (34mg/ml) and exogenous PCNA (30mg/ml) were added to the SV40 DNA replication reaction. After gel
ﬁltration, precipitated protein fractions were analyzed by immunoblotting for MSH2, RPA70 and PCNA as above. As a control for antibody
recognition, lanes marked CE contained 5ml of cell extract representing 7% of the proteins in the entire reaction.
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As p21 is known to inhibit SV40 DNA replication, we
add p21C at 20min and evaluated DNA synthesis.
Figure 6C shows that addition of p21C during DNA
replication rapidly inhibits ongoing SV40 DNA replica-
tion (within <5min of addition of p21C). Conversely,
addition of either GST alone or GST-p21C mutagenized
to not bind to PCNA [methionine 147 mutated to
alanine (55)] had no eﬀect on DNA replication
(Figure 6C). This demonstrated that p21C can readily
gain access to PCNA in replicating complexes. Finally we
addressed whether addition of p21C aﬀected the presence
of PCNA and MutS proteins on replicating complexes.
The p21C polypeptide added at 20min allowed recruit-
ment of RPA and PCNA, but MSH2 was no longer
detected (Figure 6D), whereas addition of the p21C
mutant still allowed MSH2 to remain on the replicating
complexes (Figure 6E). We conclude that addition
of p21C to replicating complexes does not result in
removal of PCNA, but does result in removal of MutS
complexes. These results suggest that p21 is able to disrupt
the interaction between PCNA and MutS complexes
through competition for binding to the multi-protein-
binding sites on PCNA. This is consistent with what is
known about MutS complexes, as both MSH3 and MSH6
proteins have been shown to interact with PCNA through
their PIP boxes (13,24,26,29). p21C also contains a
conserved PIP box, and interacts with PCNA through
the same motif (53,56). Together these ﬁndings indicate
that MMR recruitment is PCNA-dependent, and is
dependent on the availability of the multi-protein-binding
sites on PCNA. This suggests that the MMR machinery is
predominantly recruited to replicating DNA through the
interaction of MMR proteins with PCNA.
DISCUSSION
MMR is primarily a post-replicative DNA repair event.
Mismatches or insertion/deletion loops generated during
DNA replication are rapidly repaired by MMR. Earlier
studies have shown co-localization of MMR proteins to
DNA replication foci (13,57). How MMR associates with
replicating DNA has been suspected to be via known
interactions between the replicative sliding clamp, PCNA
and MMR proteins; however, until now there is no direct
evidence to support this hypothesis. In this study, we have
developed a new system to investigate the linkage between
DNA replication and MMR. This system uses the SV40
in vitro DNA replication system and DNA replication/
repair competent human cell extracts. Using this system
we showed that there is a physical association of MMR
proteins with replicating SV40 DNA which is dependent
on the presence of a functional origin of replication.
This association is dependent on PCNA and the PCNA
protein interaction motif. Earlier biochemical studies have
shown interaction of MSH3 and MSH6 proteins with
PCNA through a conserved PIP box, which interacts
with the PCNA protein interaction motif (13,14,29).
Using our system we show that the carboxyl-terminal
half of p21, containing the conserved PIP box (56), was
able to compete with MMR protein binding to PCNA on
replicating SV40 DNA. This was dependent on a
functional PIP box, as a single-point mutation in the
PIP box known to destroy PIP box function, abrogated
this eﬀect. These results indicate that binding to PCNA,
which is both present at the replication fork as well as
transiently associated with DNA following replication
fork passage, is the primary mechanism of MMR
recruitment to replicating DNA.
Figure 6. PCNA binding motif-dependent recruitment of MMR
proteins to replicating DNA Panel (A) shows an outline of the
experimental approach. After a 20min incubation, to set up active
DNA replication/repair complexes, either p21C or the p21C mutant is
added. After 10min, the complexes are subjected to gel ﬁltration and
immunoblotted as above. Panel (B) shows that at the 20min time point
that recruitment of RPA, PCNA and MSH2 to the replicating DNA
can be readily detected via immunoblotting. In Panel (C) either GST-
p21C, GST-p21C mutant or GST alone (34mg/ml of each) were added
to the replication reaction at 20min. DNA incorporation was evaluated
as described in Materials and Methods section and plotted as counts
per minute (C.P.M.) incorporated at each of the indicated times. p21C
(34mg/ml; Panel D), or p21Cmut (34mg/ml; Panel E), was added at
20min during the SV40 DNA replication reaction. The reaction was
further incubated for 10min and then subjected to gel ﬁltration.
Precipitated protein fractions were analyzed by immunoblotting for
MSH2, RPA70 and PCNA as above. As a control for antibody
recognition, lanes marked CE contained 5ml of cell extract representing
7% of the proteins in the entire reaction.
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initiates through the interaction of MutS complexes with
a mismatch (58–61), and then MutS complexes recruit
other factors such as the MutLa complex, PCNA, and
the DNA excision and re-synthesis machinery. Since
addition of the p21 C-terminus can actively displace
MutS complexes from replicating DNA, our results are
consistent with mismatches not being required for the
initial recruitment of the majority of MMR proteins to
replicating DNA. Hence, our data are consistent with the
model that PCNA may be responsible for initially
recruiting the MMR machinery to actively replicating
DNA, and actively participating in mismatch recogni-
tion (14,29). As PCNA is a sliding clamp that is capable
of greatly increasing the processivity of DNA poly-
merases, such an interaction may assist MutS complexes
to scan large regions of DNA more eﬃciently than it
could alone (62). We have shown here that PCNA plays a
role in recruitment of MMR to replicating DNA. Whether
this role of PCNA is merely to increase the localized
concentration of MutS complexes at replicating DNA to
allow for more eﬃcient MutS action in areas of newly
replicated DNA, or to actually assist MutS in scanning the
DNA for mismatches, remains unknown. However,
results shown here clearly provide support for the
model that MMR interaction with PCNA is the likely
mechanism by which MMR acts predominantly in
post-replicative manner.
Another aspect of MMR where PCNA is thought,
but not yet proven, to have a critical function is that of
strand discrimination. Our data, indicating that the
MutS complex associates with replication forks via its
interaction with PCNA, shows that PCNA is indeed
present very early during MMR, likely often prior to
mismatch recognition. Our results are therefore consistent
with the model of PCNA providing the signal for strand
discrimination at the earliest stages of MMR through
PCNA’s opposite polarity on the two newly synthesized
daughter molecules. We anticipate that this new in vitro
model system, which allows one to examine the relation-
ship between DNA replication and MMR proteins, will
provide new avenues to address the question of PCNA’s
role in MMR strand discrimination.
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